手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
8条
与
diabetes
有关的结果
Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis
2022年 发布于
Frontiers in Endocrinology
12卷 第期
Xin
C. H. Fan
H. Y. Xie
J.
et al
LUTS
benign prostatic hyperplasia
diabetes
mellitus
lower urinary tract symptoms
meta-analysis
文献简介
原文链接
Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis
2021年 发布于
Front Endocrinol (Lausanne)
12卷 第期
Xin
C. Fan
H. Xie
J. Hu
J. Sun
X. Liu
Q.
Aged
China
Databases
Factual
*Diabetes Mellitus/epidemiology
Humans
*Lower Urinary Tract Symptoms/complications/epidemiology
Male
*Prostatic Hyperplasia/complications
*Luts
*benign prostatic hyperplasia
*
diabetes
mellitus
*lower urinary tract symptoms
*meta-analysis
commercial or financial relationships that could be construed as a potential
conflict of interest.
文献简介
原文链接
卡介苗联合丝裂霉素对非肌层浸润性膀胱癌患者安全性和有效性的系统评价和 meta 分析
2021 年 发布于
European Urology
32 卷 第 6 期
刘建萍
Animals
Diabetes Mellitus/*physiopathology
Disease Progression
Humans
Obesity/*complications
Urinary Bladder Neoplasms/etiology/*pathology
all-cause mortality
cancer specific mortality
diabetes
disease recurrence
obesity
overweight
urinary bladder cancer
commercial or financial relationships that could be construed as a potential
conflict of interest.
文献简介
原文链接
Monopolar versus bipolar transurethral resection of bladder tumors An updated systematic review and meta-analysis of existing studies
2020 年 发布于
Environmental Pollution
204 卷 第 1 期
Xu J. N.
Zheng J. B.
Ma Y. C.
Diabetes Mellitus
Type 2/*drug therapy
Dose-Response Relationship
Drug
Humans
Hypoglycemic Agents/*adverse effects
Incidence
Observational Studies as Topic
Pioglitazone/*adverse effects
Risk Factors
Urinary Bladder Neoplasms/*chemically induced
文献简介
原文链接
Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis
2020 年 发布于
第三军医大学学报
37 卷 第 1 期
Feng D. C.
Li A.
Hu X.
Lin T. H.
Tang Y.
Han P.
Diabetes Mellitus
Type 2/complications/drug therapy
Humans
Hypoglycemic Agents/*adverse effects/therapeutic use
Odds Ratio
Pioglitazone/*adverse effects/therapeutic use
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Time Factors
Urinary Bladder Neoplasms/*etiology
Bladder cancer
dose-response relationship
meta-analysis
pioglitazone
文献简介
原文链接
APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis
2019 年 发布于
AJR Am J Roentgenol
16 卷 第 2 期
Bai Z. J.
Liu Q.
Wang X. S.
Liu W. Y.
Bladder cancer
Hazard ratio
Pioglitazone
Risk ratio
Type 2
diabetes
文献简介
原文链接
肌层浸润性膀胱癌新辅助化疗应用现状的 Meta 分析
2019 年 发布于
World J Urol
72 卷 第 3 期
刘伟
Aged
Diabetes Mellitus
Type 2/complications/*drug therapy
Disease Progression
Disease-Free Survival
Female
Humans
Hypoglycemic Agents/*therapeutic use
Male
Metformin/*therapeutic use
Middle Aged
Prognosis
Proportional Hazards Models
Retrospective Studies
Risk Factors
Urinary Bladder Neoplasms/etiology/*mortality
文献简介
原文链接
Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies
2019 年 发布于
BMC Cancer
4 卷 第 3 期
Giannarini G.
Crestani A.
Inferrera A.
Rossanese M.
Subba E.
Novara G.
Ficarra V.
Diabetes Mellitus/diagnosis/*drug therapy/epidemiology
Dose-Response Relationship
Drug
Humans
Hypoglycemic Agents/*adverse effects
Linear Models
Multivariate Analysis
Odds Ratio
Pioglitazone
Risk Assessment
Risk Factors
Thiazolidinediones/*adverse effects
Time Factors
Urinary Bladder Neoplasms/*chemically induced/diagnosis/epidemiology
文献简介
原文链接